Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III safety and efficacy trial of oral testosterone undecanoate in hypogonadal men
2011-001638-41Phase 3Completed
- Sponsor
- Clarus Therapeutics
- Start
- Aug 2011
- Countries
- 1
01
Overview
Phase 3, randomised trial of testosterone undecanoate in Hypoandrogenism (TD) (2 arms), sponsored by Clarus Therapeutics. Primary endpoint: Serum testosterone concentrations. Started Aug 2011; status: completed.
02
Drugs
testosterone undecanoate
03
Conditions
Hypoandrogenism (TD)
Beyond the preview
Go deeper on 2011-001638-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001638-41.